| Primary |
|
| Pierre Robin Syndrome |
100.0% |
|
| Secondary |
| Depression |
36.6% |
| Bipolar Disorder |
17.0% |
| Major Depression |
13.2% |
| Drug Use For Unknown Indication |
6.4% |
| Product Used For Unknown Indication |
4.3% |
| Anxiety |
3.4% |
| Panic Attack |
3.4% |
| Bipolar I Disorder |
2.6% |
| Schizophrenia |
2.6% |
| Schizophrenia, Paranoid Type |
2.6% |
| Psychotic Disorder |
1.7% |
| Antidepressant Therapy |
1.3% |
| Anxiety Disorder |
0.9% |
| Bulimia Nervosa |
0.9% |
| Insomnia |
0.9% |
| Lower Respiratory Tract Infection |
0.9% |
| Muscle Spasms |
0.9% |
| Tardive Dyskinesia |
0.4% |
| Urinary Retention |
0.4% |
|
| Pierre Robin Syndrome |
16.4% |
| Embolism Venous |
10.9% |
| Skin Hypertrophy |
9.1% |
| Pulmonary Embolism |
7.3% |
| Tension |
7.3% |
| Drug Interaction |
5.5% |
| Suicide Attempt |
5.5% |
| Maternal Exposure During Pregnancy |
3.6% |
| Psychotic Disorder |
3.6% |
| Suicidal Ideation |
3.6% |
| Thrombocythaemia |
3.6% |
| Tremor |
3.6% |
| Urinary Retention |
3.6% |
| Vomiting |
3.6% |
| Weight Increased |
3.6% |
| Abortion Spontaneous |
1.8% |
| Depressed Level Of Consciousness |
1.8% |
| Drug Exposure During Pregnancy |
1.8% |
| Drug Level Decreased |
1.8% |
| Dyspnoea |
1.8% |
|
| Concomitant |
| Prophylaxis |
20.4% |
| Depression |
19.6% |
| Schizophrenia |
12.7% |
| Sedation |
11.9% |
| Product Used For Unknown Indication |
4.2% |
| Bipolar Disorder |
3.7% |
| Lower Respiratory Tract Infection |
3.2% |
| Drug Use For Unknown Indication |
2.7% |
| Mania |
2.7% |
| Hypertension |
2.4% |
| Diabetes Mellitus |
2.1% |
| Pain |
2.1% |
| Antidepressant Therapy |
1.9% |
| Non-small Cell Lung Cancer |
1.6% |
| Prostate Cancer |
1.6% |
| Schizoaffective Disorder |
1.6% |
| Tourette's Disorder |
1.6% |
| Anxiety |
1.3% |
| Attention Deficit/hyperactivity Disorder |
1.3% |
| Dyspepsia |
1.3% |
|
| Schizophrenia |
16.9% |
| Withdrawal Syndrome |
13.3% |
| Drug Interaction |
8.4% |
| Weight Decreased |
8.4% |
| Suicidal Ideation |
7.2% |
| Weight Increased |
6.0% |
| Suicide Attempt |
4.8% |
| Thrombocytopenia |
4.8% |
| Oxygen Saturation Decreased |
3.6% |
| Blood Glucose Increased |
2.4% |
| Constipation |
2.4% |
| Dyspnoea |
2.4% |
| Intestinal Obstruction |
2.4% |
| Iridocyclitis |
2.4% |
| Oropharyngeal Pain |
2.4% |
| Psychotic Disorder |
2.4% |
| Pulmonary Haemorrhage |
2.4% |
| Tearfulness |
2.4% |
| Transaminases Increased |
2.4% |
| Tremor |
2.4% |
|
| Interacting |
| Depression |
33.3% |
| Schizophrenia |
16.7% |
| Product Used For Unknown Indication |
11.1% |
| Urinary Retention |
11.1% |
| Drug Use For Unknown Indication |
5.6% |
| Lower Respiratory Tract Infection |
5.6% |
| Muscle Spasms |
5.6% |
| Benign Prostatic Hyperplasia |
2.8% |
| Cerebrovascular Accident Prophylaxis |
2.8% |
| Hypertension |
2.8% |
| Urinary Tract Infection |
2.8% |
|
| Serotonin Syndrome |
44.4% |
| Suicidal Ideation |
22.2% |
| Drug Interaction |
11.1% |
| Heart Rate Increased |
11.1% |
| Tremor |
11.1% |
|
